Preliminary study of a new pathological evolution-based clinical hepatolithiasis classification
Executive Summary
Hepatolithiasis (HL), characterized by calculi in the proximal hepatic ducts, is a complex condition that often leads to biliary obstruction, infection, and irreversible liver parenchymal damage. Traditional classifications are frequently too complex for practical clinical application. This document outlines a study of a new, simplified classification system based on the pathological evolution of the disease, categorizing HL into four distinct types: Primary, Inflammatory, Mass-forming, and Terminal.
Analysis of 68 patients treated under this framework demonstrates that tailored surgical strategies—incorporating precise liver resection and choledochoscopy—yield high therapeutic efficacy. Key findings include an immediate stone clearance rate of 73.5%, a final stone clearance rate of 89.7%, and a 96.6% satisfactory postoperative quality of life among followed-up patients. This classification provides a scientific and reasonable guide for optimizing treatment strategies and improving patient outcomes.
1. Overview of Hepatolithiasis (HL)
Hepatolithiasis involves the formation of calculi within the liver's biliary tract. These stones can cause a cascade of pathological changes:
Early Stage: Biliary dilation and expansion of the liver parenchyma.
Progression: Thickening of the bile duct walls, fibrous tissue proliferation, and chronic inflammatory cell infiltration.
Advanced Stages: Segmental liver atrophy, liver abscesses, and in some cases, the development of malignancy (cholangiocarcinoma).
Terminal Stage: Secondary biliary cirrhosis and portal hypertension syndrome.
The primary goal of HL treatment is to remove lesions, extract stones, remedy strictures, and restore normal physiological function to the biliary tract.
2. Pathological Evolution-Based Classification
The study proposes a four-tier classification system designed to be more accessible for clinical decision-making than previous models.
Type I: Primary Type
Definition: Patients with no history of previous biliary tract surgery.
Clinical Features: Often presents with abdominal pain (88.2% of study cases). Stones are frequently primary and may be caused by biliary roundworms or abnormal bile metabolism.
Common Presentation: Large numbers of intrahepatic stones found at first diagnosis, often with minimal typical symptoms or severe infection initially.
=> Partial hepatectomy combined with cholecystectomy was the main surgical procedure
Type II: Inflammatory Type
Definition: Patients with a history of one or more previous biliary tract operations and recurrent cholangitis.
Clinical Features: Fever is the predominant symptom (52.0%). Previous surgeries may have caused injury to the biliary tract or the Sphincter of Oddi (SO).
Pathology: High rate of positive bile cultures (95.7%), often showing Escherichia coli, Enterococcus faecium, or Enterococcus faecalis.
=> Partial liver resection combined with cholangioenterostomy, attention needs to be paid to the different degree of stricture or short bridge loop due to previous cholangioenterostomy, or abandoned improper cholangioenterostomy
Type III: Mass-forming Type
Definition: HL complicated by intrahepatic mass-forming lesions, which may be inflammatory (abscesses) or malignant.
Clinical Features: High malignancy rate (71.4% in the study). Laboratory tests often show increased CA19-9 levels and poorer liver function (Child class B).
=> drainage and antiinfective therapy + resected liver segments
Type IV: Terminal Type
Definition: HL accompanied by secondary biliary cirrhosis and portal hypertension.
Clinical Features: Patients often have a history of repeated surgeries and present with splenomegaly, hypersplenism, or portal vein spongiform degeneration. Laboratory tests show poor liver function and prothrombin time extension.
=> poor prognosis and treatment was difficult, liver transplantation being the last option (2 case: 1) splenectomy, followed by selective secondary surgery; 2) splenectomy plus biliary tract incision to remove stones)
3. Surgical Strategy and Methodology
The study emphasizes "precise liver surgery," which focuses on excising fibrotic or atrophic parenchyma while preserving as much normal tissue as possible.
Preoperative Assessment
Comprehensive evaluation is required using:
Imaging: Doppler ultrasound, CT, and MRI/MRCP to assess stone distribution, ductal strictures, and liver atrophy.
Functional Testing: Evaluation of liver reserve and nutritional risk assessment.
Intraoperative Techniques
Liver Resection: Indicated for stones limited to one lobe with accompanying atrophy, fibrosis, or suspected malignancy.
Choledochoscopy: Performed in all cases to visualize the biliary tree, extract stones with baskets, and evaluate the Sphincter of Oddi (SO).
Biliary Drainage Selection:
External T-tube drainage: For normal SO function and complete stone removal.
Cholangioenterostomy: For cases with SO laxity (SOL).
Summary of Operative Methods (68 Patients)
4. Clinical Outcomes and Analysis
Stone Clearance Rates
The study achieved high success rates across all types using the evolution-based classification to guide surgery.
Note: Final clearance was achieved by removing residual stones postoperatively via choledochoscopy or holmium laser.
Postoperative Complications
The overall incidence of complications was 23.5% (16/68), with no perioperative deaths.
Bile Leakage: 10.3% (most common in Type II).
Pulmonary Infection: 8.8% (most common in Type I).
Incisional Infection: 5.9%.
Intraperitoneal Hemorrhage: 2.9%.
Quality of Life
Follow-up data (average 16.4 months) for 59 patients showed that 91.5% had a satisfactory quality of life. By type, the "excellent" or "good" ratings were:
Type I: 95.6%
Type II: 96.6%
Type III: 57.1% (lower due to malignancy)
Type IV: 100%
5. Conclusions
The pathological evolution-based clinical classification of HL is a scientific and practical tool that assists surgeons in optimizing treatment strategies.
Key Takeaways:
Tailored Treatment: Each type suggests a specific surgical path (e.g., partial hepatectomy for Type I; careful drainage and reconstruction for Type II).
Surgical Precision: Combining partial liver resection with choledochoscopy significantly improves immediate and final stone clearance rates.
Safety: The classification and associated surgical techniques were proven safe, with manageable complication rates and zero mortality in the study group.
Future Application: While the study is preliminary, it suggests that using this classification can lead to high patient satisfaction and improved quality of life, though further study with larger cohorts and longer follow-up is recommended.
